Abstract
Objective: To discuss the clinical study on Fengshi Qutong capsules combined with diclofenac sodium in the treatment of ankylosing spondylitis. Methods: 80 patients who were treated for ankylosing spondylitis from June 2019 to June 2020 were selected and divided into two groups. The experimental group was treated with Fengshi Qutong capsules combined with diclofenac sodium, and the control group was treated with sulfasalazine enteric-coated tablets. Results: The treatment efficacy, VAS score, BASDAI score, BASFI score, CRP level, TNF-? level, IL-I? level, and the incidence of adverse reactions between the two groups were significantly different (P<0.05). Conclusion: The application of Fengshi Qutong capsules combined with diclofenac sodium in the treatment of patients with ankylosing spondylitis is beneficial to improve the treatment efficacy, reduce the levels of CRP, TNF-?, and IL-I?, reduce the incidence of adverse reactions, and reduce the VAS, BASDAI and BASFI scores, rendering it of important clinical value.